Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia

被引：4

作者：

Lim, Yohwan ^{[1
,2
]}

Jeong, Seogsong ^{[1
,2
]}

Hong, Myunghee ^{[1
,2
]}

Han, Hyun Wook ^{[1
,2
]}

机构：

[1] CHA Univ, Sch Med, Dept Biomed Informat, Seongnam 13488, South Korea

[2] CHA Univ, Inst Biomed Informat, Sch Med, Seongnam 13488, South Korea

来源：

REVIEWS IN CARDIOVASCULAR MEDICINE | 2023年 / 24卷 / 06期

基金：

新加坡国家研究基金会;

关键词：

non-alcoholic fatty liver disease; cardiovascular disease; non-alcoholic steatohepatitis; metabolic dysfunction-associated fatty liver disease; PATHOGENESIS; ASSOCIATION; OBESITY; RISK; DYSFUNCTION; MANAGEMENT; DIAGNOSIS; STRESS; NAFLD;

D O I：

10.31083/j.rcm2406173

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to increase to over half of the adult population by 2040 globally. Since the final diagnosis of NAFLD is made by a liver biopsy, several non-invasive approaches have been developed and validated to define NAFLD and evaluate NAFLD-associated diseases. Presently, NAFLD has been identified as an important and independent risk factor for developing several extrahepatic diseases, including atherosclerosis, cardiovascular disease (CVD), diabetes, and dementia. This review discusses current findings of up-to-date literature regarding the effects of NAFLD on the risk of atherosclerosis and CVD in Asia along with potential underlying biological mechanisms and therapeutic approaches to lower the NAFLD-related CVD risk. We further focus on the difference between NAFLD and metabolic dysfunction-associated fatty liver disease (MAFLD) on the risk of CVD and its implication by comparing the risk of NAFLD and MAFLD.

引用

页数：8

共 91 条

[1] Health benefits of Mediterranean diet in nonalcoholic fatty liver disease [J].

Abenavoli, Ludovico ;

Di Renzo, Laura ;

Boccuto, Luigi ;

Alwardat, Nuha ;

Gratteri, Santo ;

De Lorenzo, Antonino .

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (09) :873-881

[2] Mediterranean diet and nonalcoholic fatty liver disease [J].

Anania, Caterina ;

Perla, Francesco Massimo ;

Olivero, Francesca ;

Pacifico, Lucia ;

Chiesa, Claudio .

WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (19) :2083-2094

[3] Pharmacological management of nonalcoholic fatty liver disease [J].

Barb, Diana ;

Portillo-Sanchez, Paola ;

Cusi, Kenneth .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08) :1183-1195

[4] The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].

Bedogni, Giorgio ;

Bellentani, Stefano ;

Miglioli, Lucia ;

Masutti, Flora ;

Passalacqua, Marilena ;

Castiglione, Anna ;

Tiribelli, Claudio .

BMC GASTROENTEROLOGY, 2006, 6 (1)

[5] The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) [J].

Buzzetti, Elena ;

Pinzani, Massimo ;

Tsochatzis, Emmanuel A. .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08) :1038-1048

[6] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].

Chalasani, Naga ;

Younossi, Zobair ;

Lavine, Joel E. ;

Charlton, Michael ;

Cusi, Kenneth ;

Rinella, Mary ;

Harrison, Stephen A. ;

Brunt, Elizabeth M. ;

Sanyal, Arun J. .

HEPATOLOGY, 2018, 67 (01) :328-357

[7]

Chen G, 2022, CLIN MOL HEPATOL

[8]

Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025

[9]

Cho HJ, 2019, GUT LIVER, V13, P440

[10] Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories [J].

Ciardullo, Stefano ;

Monti, Tommaso ;

Sala, Isabella ;

Grassi, Guido ;

Mancia, Giuseppe ;

Perseghin, Gianluca .

HYPERTENSION, 2020, 76 (02) :562-568

← 1 2 3 4 5 6 7 8 9 10 →